NEW YORK (GenomeWeb News) – Research leaders from the UK's University of Manchester and Central Manchester University Hospitals NHS Foundation Trust plan to undertake large-scale research projects with partners in Beijing, the institute said today. The projects aim to spur genomic medicine research into a range of disorders, including cancer, inherited heart disorders, blindness, and others.

Under a new memorandum of collaboration, researchers in Manchester will work with scientists at Peking University Health Science Centre, or PUHSC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.